Inverse correlation between HPSE gene single nucleotide polymorphisms and heparanase expression: Possibility of multiple levels of heparanase regulation

Journal of Leukocyte Biology

Volumn 86, Issue 2, 2009, Pages 445-455

  Ostrovsky, Olga ^a   Korostishevsky, Michael ^b   Shafat, Itay ^c   Mayorov, Margarita ^a   Ilan, Neta ^c   Vlodavsky, Israel ^c   Nagler, Arnon ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Cytokines; Health individuals; Heparan sulfate proteoglycans; Leukocytes

Indexed keywords

HEPARANASE; MESSENGER RNA; PLASMA PROTEIN; PROTEIN; PROTEOHEPARAN SULFATE; BETA GLUCURONIDASE; MEMBRANE ANTIGEN;

ADULT; ARTICLE; AUTOIMMUNITY; BLOOD LEVEL; CELL SURFACE; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; GENE SEGREGATION; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEPARANASE GENE; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; MALE; METASTASIS; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE REPAIR; ADOLESCENT; BLOOD; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC SCREENING; GENETICS; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; UPREGULATION;

ADOLESCENT; ADULT; ANTIGENS, SURFACE; DNA MUTATIONAL ANALYSIS; DOWN-REGULATION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE FREQUENCY; GENETIC SCREENING; GENOTYPE; GLUCURONIDASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER; UP-REGULATION; YOUNG ADULT;

EID: 69449093846     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1208735     Document Type: Article

References (64)

1. Vlodavsky, I., Friedmann, Y. (2001) Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J. Clin. Invest. 108, 341-347. (Pubitemid 32730777)
2. Sanderson, R. D., Yang, Y., Suva, L. J., Kelly, T. (2004) Heparan sulfate proteoglycans and heparanase - partners in osteolytic tumor growth and metastasis. Matrix Biol. 23, 341-352. (Pubitemid 39469549)
3. Vlodavsky, I., Miao, H. Q., Medalion, B., Danagher, P., Ron, D. (1996) Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev. 15, 177-186. (Pubitemid 26236115)
4. Parish, C. R., Freeman, C., Hulett, M. D. (2001) Heparanase: a key enzyme involved in cell invasion. Biochim. Biophys. Acta 1471, M99-M108. (Pubitemid 32206686)
5. Ilan, N., Elkin, M., Vlodavsky, I. (2006) Regulation, function, and clinical significance of heparanase in cancer metastasis and angiogenesis. Int. J. Biochem. Cell Biol. 38, 2018-2039. (Pubitemid 44397619)
6. Vreys, V., David, G. (2007) Mammalian heparanase: what is the message? J. Cell. Mol. Med. 11, 427-452. (Pubitemid 47153456)
7. Nobuhisa, T., Naomoto, Y., Okawa, K., Takaoka, M., Gunduz, M., Motoki, T., Nagatsuka, H., Tsujigiwa, H., Shirakawa, Y., Yamatsuji, T., et al. (2007) Translocation of heparanase into nucleus results in cell differentiation. Cancer Sci. 98, 535-540. (Pubitemid 46562744)
8. Doweck, I., Kaplan-Cohen, V., Naroditsky, I., Sabo, E., Ilan, N., Vlodavsky, I. (2006) Heparanase localization and expression by head and neck cancer: correlation with tumor progression and patient survival. Neoplasia 8, 1055-1061. (Pubitemid 44936155)
9. Nasser, N. J. (2008) Heparanase involvement in physiology and disease. Cell. Mol. Life Sci. 65, 1706-1715.
10. Mollinedo, F., Nakajima, M., Llorens, A., Barbosa, E., Callejo, S., Gajate, C., Fabra, A. (1997) Major co-localization of the ECM-degradative enzymes heparanase and gelatinase in tertiary granules of human neutrophils. Biochem. J. 327, 917-923. (Pubitemid 27487702)
11. Kosir, M. A., Foley-Loudon, P. A., Finkenauer, R., Tennenberg, S. D. (2002) Multiple heparanases are expressed in polymorphonuclear cells. J. Surg. Res. 103, 100-108. (Pubitemid 34953398)
12. Dempsey, L. A., Plummer, T. B., Coombes, S., Platt, J. L. (2000) Platelet heparanase in vascular responses to xenotransplantation. Transplant. Proc. 32, 927. (Pubitemid 30601833)
13. Saadi, S., Wrenshall, L. E., Platt, J. L. (2002) Regional manifestations and control of the immune system. FASEB J. 16, 849-856. (Pubitemid 34615134)
14. Nadav, L., Eldor, A., Yacoby-Zeevi, O., Zamir, E., Pecker, I., Ilan, N., Geiger, B., Vlodavsky, I., Katz, B. Z. (2002) Activation, processing and trafficking of extracellular heparanase by primary human fibloblasts. J. Cell Sci. 115, 2179-2187. (Pubitemid 34746383)
15. Vaday, G. G., Lider, O. (2000) Extracellular matrix moieties, cytokines, and enzymes: dynamic effects on immune cell behavior and inflammation. J. Leukoc. Biol. 67, 149-159.
16. Sotnikov, I., Hershkovitz, R., Grabovsky, V., Ilan, N., Cahalon, L., Vlodavsky, I., Alon, R., Lider, O. (2004) Enzymatically quiescent heparanase augments T cell interactions with VCAM-1 and extracellular matrix components under versatile dynamic contexts. J. Immunol. 172, 5185-5193. (Pubitemid 38542014)
17. Vlodavsky, I., Eldor, A., Haimovitz-Friedman, A., Matzner, Y., Ishai-Michaeli, R., Lider, O., Naparstek, Y., Cohen, I. R., Fuks, Z. (1992) Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis 12, 112-127.
18. Vlodavsky, I., Goldshmidt, O., Zcharia, E., Atzmon, R., Rangini-Guatta, Elkin, M., Peretz, T., Friedmann, Y. (2002) Mammalian heparanase: involvement in cancer metastasis, angiogenesis, and normal development. Semin. Cancer Biol. 12, 121-129. (Pubitemid 34680741)
19. Gilat, D., Hershkoviz, R., Goldkorn, I., Cahalon, L., Korner, G., Vlodavsky, I., Lider, O. (1995) Molecular behavior adapts to context: heparanase functions as an extracellular matrix degrading enzyme or as a T cell adhesion molecule depending on the local pH. J. Exp. Med. 181, 1929-1934.
20. Goldshmidt, O., Zcharia, E., Cohen, M., Aingorn, H., Cohen, I., Nadav, L., Katz, B. Z., Geiger, B., Vlodavsky, I. (2003) Heparanase mediates cell adhesion independent of its enzymatic activity. FASEB J. 17, 1015-1025. (Pubitemid 36676388)
21. Goldshmidt, O., Zcharia, E., Abramovitch, R., Metzger, S., Aingorn, H., Friedmann, Y., Schirrmacher, V., Mitrani, E., Vlodavsky, I. (2002) Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis. Proc. Natl. Acad. Sci. USA 99, 10031-10036. (Pubitemid 34831167)
22. Edovitsky, E., Lerner, E., Zcharia, E., Vlodavsky, V., Elkin, M. (2006) Role of endothelial heparanase in delayed-type hypersensitivity. Blood 107, 3609-3616.
23. Maxhimer, J. B., Somenek, M., Rao, G., Pesce, C. E., Baldwin, D., Gattuso, P., Schwartz, M. M., Lewis, E. J., Prinz, R. A., Xu, X. (2005) Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells: a potential role in the pathogenesis of proteinuria in diabetic patients. Diabetes 54, 2172-2178. (Pubitemid 40911281)
24. van den Hoven, M. J., Rops, A. L., Vlodavsky, I., Levidiotis, V., Berden, J. H., van der Vlag, J. (2007) Heparanase in glomerular diseases. Kidney Int. 72, 543-548.
25. Waterman, M., Ben-Izhak, O., Eliakim, R., Groisman, G., Vlodavsky, I., Ilan, N. (2007) Heparanase upregulation by colonic epithelium of inflammatory bowel disease. Mod. Pathol. 20, 878-888. (Pubitemid 44967944)
26. Chen, G., Wang, D., Vikramadithyan, R., Yagyu, H., Saxena, U., Pillarisetti, S., Goldberg, I. J. (2004) Inflammatory cytokines and fatty acids regulate endothelial cell heparanase expression. Biochemistry 43, 4971-4977. (Pubitemid 38544450)
27. Levidiotis, V., Freeman, C., Tikellis, C., Cooper, M. E., Power, D. A. (2004) Heparanase is involved in the pathogenesis of proteinuria as a result of gromerulonephritis. J. Am. Soc. Nephrol. 15, 68-78. (Pubitemid 38020699)
28. Cohen-Mazor, M., Sela, S., Mazor, R., Ilan, N., Vlodavsky, I., Rops, A. L., van der Vlag, J., Cohen, H. I., Kristal, B. (2008) Are primed polymorphonuclear leukocytes contributors to the high heparanase levels in hemodialysis patients? Am. J. Physiol. Heart Circ. Physiol. 294, H651-H658. (Pubitemid 351253276)
29. Zcharia, E., Zilka, R., Yaar, A., Yacoby-Zeevi, O., Zetser, A., Metzger, S., Sarid, R., Naggi, A., Casu, B., Ilan, N., et al. (2005) Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models. FASEB J. 19, 211-221. (Pubitemid 40192578)
30. Ali, S., Hardy, L. A., Kirby, J. A. (2003) Transplant immunobiology: a crucial role for heparan sulfate glycosaminoglycans. Transplantation 75, 1773-1782. (Pubitemid 36734630)
31. Vlodavsky, I., Friedmann, Y., Elkin, M., Aingorn, H., Atzmon, R., Ishai-Michael, R., Bitan, M., Pappo, O., Peretz, T., Michal, I., et al. (1999) Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat. Med. 5, 793-802. (Pubitemid 29318614)
32. Hulett, M. D., Freeman, C., Hamdorf, B. J., Baker, R. T., Harris, M. J., Parish, C. R. (1999) Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat. Med. 5, 803-809. (Pubitemid 29318615)
33. Bitan, M., Polliack, A., Zecchina, G., Nagler, A., Friedmann, Y., Nadav, L., Deutsch, V., Pecker, I., Eldor, A., Vlodavsky, I., et al. (2002) Heparanase expression in human leukemias is restricted to acute myeloid leukemias. Exp. Hematol. 30, 34-41. (Pubitemid 34059215)
34. Abboud-Jarrous, G., Aingorn, H., Rangini-Guetta, Z., Atzmon, R., Elgavish, S., Peretz, T., Vlodavsky, I. (2005) Heparanase processing: site-direct mutagenesis, proteolytic cleavage and activation. J. Biol. Chem. 280, 13568-13575. (Pubitemid 40517249)
35. Abboud-Jarrous, G., Atzmon, R., Peretz, T., Palermo, C., Gadea, B. B., Joyce, J. A., Vlodavsky, I. (2008) Cathepsin L is responsible for processing and activation of proheparanase through multiple cleavages of a linker segments. J. Biol. Chem. 283, 18167-18176.
36. Ostrovsky, O., Korostishevsky, M., Levite, I., Leiba, M., Galski, H., Gazit, E., Vlodavsky, I., Nagler, A. (2007) Characterization of HPSE gene single nucleotide polymorphisms in Jewish populations of Israel. Acta Haematol. 117, 57-64. (Pubitemid 46012426)
37. Ostrovsky, O., Korostishevsky, M., Levite, I., Leiba, M., Galski, H., Vlodavsky, I., Nagler, A. (2007) Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies. Leukemia 21, 2296-2303. (Pubitemid 350011702)
38. Shafat, I., Zcharia, E., Nisman, B., Nadir, Y., Makhoul, F., Vlodavsky, I., Ilan, N. (2006) An ELISA method for the detection and quantification of human heparanase. Biochem. Biophys. Res. Commun. 341, 958-963. (Pubitemid 43221759)
39. Abramson, J. H., Gahlinger, P. M. (1999) Computer Program for Epidemiologists. PEPI version 3, Brixton Books: London.
40. Komlos, L., Korostishevsky, M., Livni, E., Halbrecht, I., Vardimon, D., Ben-Rafael, Z., Klein, T. (1997) Possible sex-correlated transmission of maternal class I HLA haplotypes. Eur. J. Immunogenet. 24, 169-177. (Pubitemid 27250010)
41. Schneider, S., Roessli, D., Excoffier, L. (2000) A Software for Population Genetic Data Analysis. Manual Arlequin, version 2.00, University of Geneva: Switzerland.
42. Nei, M. (1987) Molecular Evolutionary Genetics. Columbia University Press: New York, USA.
43. Slatkin, M. (1994) Linkage disequilibrium in growing and stable population. Genetics 137, 331-336.
44. Slatkin, M., Excoffier, L. (1996) Testing for linkage disequilibrium in genotypic data using the EM algorithm. Heredity 76, 377-383.
45. Guo, S. W., Thomson, E. A. (1992) Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 48, 361-372.
46. Excoffier, L., Slatkin, M. (1995) Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol. Biol. Evol. 12, 921-927.
47. Korostishevsky, M., Kremer, I., Kaganovich, M., Cholostoy, A., Murad, I., Muhaheed, M., Bannoura, I., Rietschel, M., Dobrusin, M., Bening-Abu-Shach, U., Belmaker, R. H., Maier, W., Ebstein, R. P., Navon, R. (2006) Transmission disequilibrium and haplotype analysis of the G72/G30 locus: suggestive linkage to schizophrenia in Palestinian Arabs living in North of Israel. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 141, 91-95. (Pubitemid 43062549)
48. McKenzie, E. A. (2007) Heparanase: a target for drug discovery in cancer and inflammation. Br. J. Pharmacol. 151, 1-14. (Pubitemid 46675998)
49. Fridman, R., Lider, O., Naparstek, Y., Fuks, Z., Vlodavsky, I., Cohen, I. R. (1987) Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparin sulfate moiety of subendothelial extracellular matrix. J. Cell. Physiol. 130, 85-92. (Pubitemid 17011051)
50. Naparstek, Y., Cohen, F. R., Fuks, Z., Vlodavsky, I. (1984) Activated T lymphocytes produce a matrix-degrading heparin sulfate endoglycosidase. Nature 310, 241-244. (Pubitemid 14090715)
51. Chanock, S.J., Taylor VI, J.G. (2002) Using genetic variation to study immunomodulation. Curr. Opin. Pharmacol. 2, 463-469.
52. Chanock, S. (2001) Candidate genes and single nucleotide polymorphisms (SNPs) in the study of human disease. Dis. Markers 17, 89-98. (Pubitemid 32964840)
53. Shafat, I., Vlodavsky, I., Ilan, N. (2006) Characterization of mechanisms involved in secretion of active heparanase. J. Biol. Chem. 281, 23804-23811. (Pubitemid 44274156)
54. Lio, D., Candore, G., Crivello, A., Scola, L., Colonna-Romano, G., Cavallone, L., Hoffmann, E., Caruso, M., Licastro, F., Caldarera, C. M., et al. (2004) Opposite effect of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease. J. Med. Genet. 41, 790-794. (Pubitemid 39389298)
55. Suarez, A., Castro, P., Alonso, R., Mozo, L., Gutierrez, C. (2003) Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation 75, 711-717. (Pubitemid 36337373)
56. Tesse, R., Cardinale, F., Santostasi, T., Polizzi, A., Mappa, L., Manca, A., De Robertis, F., Silecchia, O., Armenio, L. (2008) Association of interleukin-10 gene haplotypes with Pseudomonas aeruginosa airway colonization in cystic fibrosis. J. Cyst. Fibros. 7, 329-332.
57. Helminen, M., Nuolivirta, K., Virta, M., Halkosalo, A., Korppi, M., Vesikari, T., Hurme, M. (2008) IL-10 gene polymorphism at -1082 A/G is associated with severe rhinovirus bronchiolitis in infants. Pediatr. Pulmonol. 43, 391-395. (Pubitemid 351544048)
58. Ihrcke, N. S., Parker, W., Reissner, K. J., Platt, J. L. (1998) Regulation of platelet heparanase during inflammation: role of pH and proteinase. J. Cell. Physiol. 175, 255-267. (Pubitemid 28198205)
59. Revel, A., Helman, A., Koler, M., Shushan, A., Goldshmidt, O., Zcharia, E., Aingorn, H., Vlodavsky, I. (2005) Heparanase improves mouse embryo implantation. Fertil. Steril. 83, 580-586. (Pubitemid 40348567)
60. Zcharia, E., Zilka, R., Yaar, A., Yacoby-Zeevi, O., Zetser, A., Metzger, S., Sarid, R., Naggi, A., Casu, B., Ilan, N., et al. (2005) Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models. FASEB J. 19, 211-221. (Pubitemid 40192578)
61. Zcharia, E., Philip, D., Edovitsky, E., Aingorn, H., Metzger, S., Kleinman, H. K., Vlodavsky, I., Elkin, M. (2005) Heparanase regulates murine hair growth. Am. J. Pathol. 166, 999-1008. (Pubitemid 40524425)
62. Spiegel, A., Zcharia, E., Vaqima, Y., Itkin, T., Kalinkovich, A., Dar, A., Kollet, O., Netzer, N., Golan, K., Shafat, I., et al. (2008) Heparanase regulates retention and proliferation of primitive Sca-1+/c-kit+/Lin- cells via modulation of the bone marrow microenvironment. Blood 111, 4934-4943.
63. Zcharia, E., Metzger, S., Chajek-Shaul, T., Aingorn, H., Elkin, M., Friedmann, Y., Weinstein, T., Li, J. P., Lindahl, V., Vlodavsky, I. (2004) Transgenic expression of mammalian heparanase uncover physiological function of heparin sulfate in tissue morphogenesis, vascularization, and feeding behavior. FASEB J. 18, 252-263. (Pubitemid 38186244)
64. Takaoka, M., Naomoto, Y., Ohkawa, T., Uetsuka, H., Shirakawa, Y., Uno, F., Fujiwara, T., Gunduz, M., Nagatsuka, H., Nakajima, M., et al. (2003) Heparanase expression correlates with invasion and poor prognosis in gastric cancer. Lab. Invest. 83, 613-622. (Pubitemid 36618040)